INGRAM DOUGLAS S 4
4 · Sarepta Therapeutics, Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
INGRAM DOUGLAS S
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2020-12-31$170.49/sh−37,144$6,332,681→ 357,868 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.